Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer

BACKGROUND: After radical prostatectomy (RP), depending on stage, up to 40% of patients with prostate cancer (PCa) will experience biochemical failure (BF). Despite salvage therapy, approximately one-third of these patients will need permanent hormone therapy (pHT) and are at risk of progression to...

Descripción completa

Detalles Bibliográficos
Autores principales: Guldvik, Ingrid Jenny, Braadland, Peder Rustøen, Sivanesan, Shivanthe, Ramberg, Håkon, Kristensen, Gitte, Tennstedt, Pierre, Røder, Andreas, Schlomm, Thorsten, Berge, Viktor, Eri, Lars Magne, Lilleby, Wolfgang, Mills, Ian G., Taskén, Kristin Austlid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637679/
https://www.ncbi.nlm.nih.gov/pubmed/36353660
http://dx.doi.org/10.1016/j.euros.2022.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637679/
https://www.ncbi.nlm.nih.gov/pubmed/36353660
http://dx.doi.org/10.1016/j.euros.2022.09.002

Ejemplares similares